Differentiation potential of human CD133 positive hematopoietic stem cells into motor neuron- like cells, in vitro

•Human cord blood CD133+ cells acquired motor neuron-like characteristics after exposure to RA, Shh and BDNF.•The cells could express motor neuron markers such as Isl-1, SMI-32 and AChE as indicated by flowcytometry.•The differentiated CD133+ cells could express motor neuron related genes at levels...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of chemical neuroanatomy 2017-12, Vol.86, p.35-40
Hauptverfasser: Moghaddam, Sepideh Alavi, Yousefi, Behnam, Sanooghi, Davood, Faghihi, Faezeh, Hayati Roodbari, Nasim, Bana, Nikoo, Joghataei, Mohammad Taghi, Pooyan, Paria, Arjmand, Babak
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 40
container_issue
container_start_page 35
container_title Journal of chemical neuroanatomy
container_volume 86
creator Moghaddam, Sepideh Alavi
Yousefi, Behnam
Sanooghi, Davood
Faghihi, Faezeh
Hayati Roodbari, Nasim
Bana, Nikoo
Joghataei, Mohammad Taghi
Pooyan, Paria
Arjmand, Babak
description •Human cord blood CD133+ cells acquired motor neuron-like characteristics after exposure to RA, Shh and BDNF.•The cells could express motor neuron markers such as Isl-1, SMI-32 and AChE as indicated by flowcytometry.•The differentiated CD133+ cells could express motor neuron related genes at levels comparable with the undifferentiated cells. Spinal cord injuries and motor neuron-related disorders impact on life of many patients around the world. Since pharmacotherapy and surgical approaches were not efficient to regenerate these types of defects; stem cell therapy as a good strategy to restore the lost cells has become the focus of interest among the scientists. Umbilical cord blood CD133+ hematopoietic stem cells (UCB- CD133+ HSCs) with self- renewal property and neural lineage differentiation capacity are ethically approved cell candidate for use in regenerative medicine. In this regard the aim of this study was to quantitatively evaluate the capability of these cells to differentiate into motor neuron-like cells (MNL), in vitro. CD133+ HSCs were isolated from human UCB using MACS system. After cell characterization using flow cytometry, the cells were treated with a combination of Retinoic acid, Sonic hedgehog, Brain derived neurotrophic factor, and B27 through a 2- step procedure for two weeks. The expression of MN-specific markers was examined using qRT- PCR, flow cytometry and immunocytochemistry. By the end of the two-week differentiation protocol, CD133+ cells acquired unipolar MNL morphology with thin and long neurites. The expression of Isl-1(62.15%), AChE (41.83%), SMI-32 (21.55%) and Nestin (17.46%) was detected using flow cytometry and immunocytochemistry. The analysis of the expression of PAX6, ISL-1, ACHE, CHAT and SMI-32 revealed that MNLs present these neural markers at levels comparable with undifferentiated cells. In Conclusion Human UCB- CD133+ HSCs are remarkably potent cell candidates to transdifferentiate into motor neuron-like cells, in vitro.
doi_str_mv 10.1016/j.jchemneu.2017.07.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1924595658</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0891061817300777</els_id><sourcerecordid>1924595658</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-9e2e311262d41bdf3a174517267525f121c66f594fd99ce30253e4df5ffb01853</originalsourceid><addsrcrecordid>eNqFUMFu2zAMFYYOS5btFwIde6hTUbJk-7Yi2dYCAXbZzoIjU4gy28okOUD_vsrS9FqAAEG8R77HR8gS2AoYqPvD6mD2OIw4rTiDasVyMfWBzKGuRKEEYzdkzuoGCqagnpHPMR4YAylK9YnMeF3JUgGfk7Bx1mLAMbk2OT_So0__h556S_fT0I50vQEhMhBdciekWbZN_ugdJmdoTDhQg30fqRuTp4NPPtDsK_ixoL37ixf0LsP05FLwX8hH2_YRv772Bfnz4_vv9WOx_fXzaf2wLUypmlQ0yFEAcMW7EnadFS1UpYSKq0pyaYGDUcrKprRd0xgUjEuBZWeltTsGtRQLcnu5ewz-34Qx6cHFs5d2RD9FDQ0vZSOVrDNVXagm-BgDWn0MbmjDswamz3nrg77mrc95a5aLqby4fNWYdgN2b2vXgDPh24WA-dOTw6CjcTga7FxAk3Tn3XsaL-jAlU8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1924595658</pqid></control><display><type>article</type><title>Differentiation potential of human CD133 positive hematopoietic stem cells into motor neuron- like cells, in vitro</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Moghaddam, Sepideh Alavi ; Yousefi, Behnam ; Sanooghi, Davood ; Faghihi, Faezeh ; Hayati Roodbari, Nasim ; Bana, Nikoo ; Joghataei, Mohammad Taghi ; Pooyan, Paria ; Arjmand, Babak</creator><creatorcontrib>Moghaddam, Sepideh Alavi ; Yousefi, Behnam ; Sanooghi, Davood ; Faghihi, Faezeh ; Hayati Roodbari, Nasim ; Bana, Nikoo ; Joghataei, Mohammad Taghi ; Pooyan, Paria ; Arjmand, Babak</creatorcontrib><description>•Human cord blood CD133+ cells acquired motor neuron-like characteristics after exposure to RA, Shh and BDNF.•The cells could express motor neuron markers such as Isl-1, SMI-32 and AChE as indicated by flowcytometry.•The differentiated CD133+ cells could express motor neuron related genes at levels comparable with the undifferentiated cells. Spinal cord injuries and motor neuron-related disorders impact on life of many patients around the world. Since pharmacotherapy and surgical approaches were not efficient to regenerate these types of defects; stem cell therapy as a good strategy to restore the lost cells has become the focus of interest among the scientists. Umbilical cord blood CD133+ hematopoietic stem cells (UCB- CD133+ HSCs) with self- renewal property and neural lineage differentiation capacity are ethically approved cell candidate for use in regenerative medicine. In this regard the aim of this study was to quantitatively evaluate the capability of these cells to differentiate into motor neuron-like cells (MNL), in vitro. CD133+ HSCs were isolated from human UCB using MACS system. After cell characterization using flow cytometry, the cells were treated with a combination of Retinoic acid, Sonic hedgehog, Brain derived neurotrophic factor, and B27 through a 2- step procedure for two weeks. The expression of MN-specific markers was examined using qRT- PCR, flow cytometry and immunocytochemistry. By the end of the two-week differentiation protocol, CD133+ cells acquired unipolar MNL morphology with thin and long neurites. The expression of Isl-1(62.15%), AChE (41.83%), SMI-32 (21.55%) and Nestin (17.46%) was detected using flow cytometry and immunocytochemistry. The analysis of the expression of PAX6, ISL-1, ACHE, CHAT and SMI-32 revealed that MNLs present these neural markers at levels comparable with undifferentiated cells. In Conclusion Human UCB- CD133+ HSCs are remarkably potent cell candidates to transdifferentiate into motor neuron-like cells, in vitro.</description><identifier>ISSN: 0891-0618</identifier><identifier>EISSN: 1873-6300</identifier><identifier>DOI: 10.1016/j.jchemneu.2017.07.006</identifier><identifier>PMID: 28754612</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>AC133 Antigen - physiology ; CD133 ; Cell Count ; Cell Differentiation - physiology ; Cells, Cultured ; Cord Blood Stem Cell Transplantation ; Gene Expression ; Hematopoietic stem cell ; Hematopoietic Stem Cells - physiology ; Humans ; Immunohistochemistry ; Motor neuron ; Motor Neurons - physiology ; Nerve Tissue Proteins - metabolism ; Umbilical cord blood</subject><ispartof>Journal of chemical neuroanatomy, 2017-12, Vol.86, p.35-40</ispartof><rights>2017</rights><rights>Copyright © 2017. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-9e2e311262d41bdf3a174517267525f121c66f594fd99ce30253e4df5ffb01853</citedby><cites>FETCH-LOGICAL-c469t-9e2e311262d41bdf3a174517267525f121c66f594fd99ce30253e4df5ffb01853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jchemneu.2017.07.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28754612$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moghaddam, Sepideh Alavi</creatorcontrib><creatorcontrib>Yousefi, Behnam</creatorcontrib><creatorcontrib>Sanooghi, Davood</creatorcontrib><creatorcontrib>Faghihi, Faezeh</creatorcontrib><creatorcontrib>Hayati Roodbari, Nasim</creatorcontrib><creatorcontrib>Bana, Nikoo</creatorcontrib><creatorcontrib>Joghataei, Mohammad Taghi</creatorcontrib><creatorcontrib>Pooyan, Paria</creatorcontrib><creatorcontrib>Arjmand, Babak</creatorcontrib><title>Differentiation potential of human CD133 positive hematopoietic stem cells into motor neuron- like cells, in vitro</title><title>Journal of chemical neuroanatomy</title><addtitle>J Chem Neuroanat</addtitle><description>•Human cord blood CD133+ cells acquired motor neuron-like characteristics after exposure to RA, Shh and BDNF.•The cells could express motor neuron markers such as Isl-1, SMI-32 and AChE as indicated by flowcytometry.•The differentiated CD133+ cells could express motor neuron related genes at levels comparable with the undifferentiated cells. Spinal cord injuries and motor neuron-related disorders impact on life of many patients around the world. Since pharmacotherapy and surgical approaches were not efficient to regenerate these types of defects; stem cell therapy as a good strategy to restore the lost cells has become the focus of interest among the scientists. Umbilical cord blood CD133+ hematopoietic stem cells (UCB- CD133+ HSCs) with self- renewal property and neural lineage differentiation capacity are ethically approved cell candidate for use in regenerative medicine. In this regard the aim of this study was to quantitatively evaluate the capability of these cells to differentiate into motor neuron-like cells (MNL), in vitro. CD133+ HSCs were isolated from human UCB using MACS system. After cell characterization using flow cytometry, the cells were treated with a combination of Retinoic acid, Sonic hedgehog, Brain derived neurotrophic factor, and B27 through a 2- step procedure for two weeks. The expression of MN-specific markers was examined using qRT- PCR, flow cytometry and immunocytochemistry. By the end of the two-week differentiation protocol, CD133+ cells acquired unipolar MNL morphology with thin and long neurites. The expression of Isl-1(62.15%), AChE (41.83%), SMI-32 (21.55%) and Nestin (17.46%) was detected using flow cytometry and immunocytochemistry. The analysis of the expression of PAX6, ISL-1, ACHE, CHAT and SMI-32 revealed that MNLs present these neural markers at levels comparable with undifferentiated cells. In Conclusion Human UCB- CD133+ HSCs are remarkably potent cell candidates to transdifferentiate into motor neuron-like cells, in vitro.</description><subject>AC133 Antigen - physiology</subject><subject>CD133</subject><subject>Cell Count</subject><subject>Cell Differentiation - physiology</subject><subject>Cells, Cultured</subject><subject>Cord Blood Stem Cell Transplantation</subject><subject>Gene Expression</subject><subject>Hematopoietic stem cell</subject><subject>Hematopoietic Stem Cells - physiology</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Motor neuron</subject><subject>Motor Neurons - physiology</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Umbilical cord blood</subject><issn>0891-0618</issn><issn>1873-6300</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUMFu2zAMFYYOS5btFwIde6hTUbJk-7Yi2dYCAXbZzoIjU4gy28okOUD_vsrS9FqAAEG8R77HR8gS2AoYqPvD6mD2OIw4rTiDasVyMfWBzKGuRKEEYzdkzuoGCqagnpHPMR4YAylK9YnMeF3JUgGfk7Bx1mLAMbk2OT_So0__h556S_fT0I50vQEhMhBdciekWbZN_ugdJmdoTDhQg30fqRuTp4NPPtDsK_ixoL37ixf0LsP05FLwX8hH2_YRv772Bfnz4_vv9WOx_fXzaf2wLUypmlQ0yFEAcMW7EnadFS1UpYSKq0pyaYGDUcrKprRd0xgUjEuBZWeltTsGtRQLcnu5ewz-34Qx6cHFs5d2RD9FDQ0vZSOVrDNVXagm-BgDWn0MbmjDswamz3nrg77mrc95a5aLqby4fNWYdgN2b2vXgDPh24WA-dOTw6CjcTga7FxAk3Tn3XsaL-jAlU8</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Moghaddam, Sepideh Alavi</creator><creator>Yousefi, Behnam</creator><creator>Sanooghi, Davood</creator><creator>Faghihi, Faezeh</creator><creator>Hayati Roodbari, Nasim</creator><creator>Bana, Nikoo</creator><creator>Joghataei, Mohammad Taghi</creator><creator>Pooyan, Paria</creator><creator>Arjmand, Babak</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201712</creationdate><title>Differentiation potential of human CD133 positive hematopoietic stem cells into motor neuron- like cells, in vitro</title><author>Moghaddam, Sepideh Alavi ; Yousefi, Behnam ; Sanooghi, Davood ; Faghihi, Faezeh ; Hayati Roodbari, Nasim ; Bana, Nikoo ; Joghataei, Mohammad Taghi ; Pooyan, Paria ; Arjmand, Babak</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-9e2e311262d41bdf3a174517267525f121c66f594fd99ce30253e4df5ffb01853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>AC133 Antigen - physiology</topic><topic>CD133</topic><topic>Cell Count</topic><topic>Cell Differentiation - physiology</topic><topic>Cells, Cultured</topic><topic>Cord Blood Stem Cell Transplantation</topic><topic>Gene Expression</topic><topic>Hematopoietic stem cell</topic><topic>Hematopoietic Stem Cells - physiology</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Motor neuron</topic><topic>Motor Neurons - physiology</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Umbilical cord blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moghaddam, Sepideh Alavi</creatorcontrib><creatorcontrib>Yousefi, Behnam</creatorcontrib><creatorcontrib>Sanooghi, Davood</creatorcontrib><creatorcontrib>Faghihi, Faezeh</creatorcontrib><creatorcontrib>Hayati Roodbari, Nasim</creatorcontrib><creatorcontrib>Bana, Nikoo</creatorcontrib><creatorcontrib>Joghataei, Mohammad Taghi</creatorcontrib><creatorcontrib>Pooyan, Paria</creatorcontrib><creatorcontrib>Arjmand, Babak</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of chemical neuroanatomy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moghaddam, Sepideh Alavi</au><au>Yousefi, Behnam</au><au>Sanooghi, Davood</au><au>Faghihi, Faezeh</au><au>Hayati Roodbari, Nasim</au><au>Bana, Nikoo</au><au>Joghataei, Mohammad Taghi</au><au>Pooyan, Paria</au><au>Arjmand, Babak</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differentiation potential of human CD133 positive hematopoietic stem cells into motor neuron- like cells, in vitro</atitle><jtitle>Journal of chemical neuroanatomy</jtitle><addtitle>J Chem Neuroanat</addtitle><date>2017-12</date><risdate>2017</risdate><volume>86</volume><spage>35</spage><epage>40</epage><pages>35-40</pages><issn>0891-0618</issn><eissn>1873-6300</eissn><abstract>•Human cord blood CD133+ cells acquired motor neuron-like characteristics after exposure to RA, Shh and BDNF.•The cells could express motor neuron markers such as Isl-1, SMI-32 and AChE as indicated by flowcytometry.•The differentiated CD133+ cells could express motor neuron related genes at levels comparable with the undifferentiated cells. Spinal cord injuries and motor neuron-related disorders impact on life of many patients around the world. Since pharmacotherapy and surgical approaches were not efficient to regenerate these types of defects; stem cell therapy as a good strategy to restore the lost cells has become the focus of interest among the scientists. Umbilical cord blood CD133+ hematopoietic stem cells (UCB- CD133+ HSCs) with self- renewal property and neural lineage differentiation capacity are ethically approved cell candidate for use in regenerative medicine. In this regard the aim of this study was to quantitatively evaluate the capability of these cells to differentiate into motor neuron-like cells (MNL), in vitro. CD133+ HSCs were isolated from human UCB using MACS system. After cell characterization using flow cytometry, the cells were treated with a combination of Retinoic acid, Sonic hedgehog, Brain derived neurotrophic factor, and B27 through a 2- step procedure for two weeks. The expression of MN-specific markers was examined using qRT- PCR, flow cytometry and immunocytochemistry. By the end of the two-week differentiation protocol, CD133+ cells acquired unipolar MNL morphology with thin and long neurites. The expression of Isl-1(62.15%), AChE (41.83%), SMI-32 (21.55%) and Nestin (17.46%) was detected using flow cytometry and immunocytochemistry. The analysis of the expression of PAX6, ISL-1, ACHE, CHAT and SMI-32 revealed that MNLs present these neural markers at levels comparable with undifferentiated cells. In Conclusion Human UCB- CD133+ HSCs are remarkably potent cell candidates to transdifferentiate into motor neuron-like cells, in vitro.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28754612</pmid><doi>10.1016/j.jchemneu.2017.07.006</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0891-0618
ispartof Journal of chemical neuroanatomy, 2017-12, Vol.86, p.35-40
issn 0891-0618
1873-6300
language eng
recordid cdi_proquest_miscellaneous_1924595658
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects AC133 Antigen - physiology
CD133
Cell Count
Cell Differentiation - physiology
Cells, Cultured
Cord Blood Stem Cell Transplantation
Gene Expression
Hematopoietic stem cell
Hematopoietic Stem Cells - physiology
Humans
Immunohistochemistry
Motor neuron
Motor Neurons - physiology
Nerve Tissue Proteins - metabolism
Umbilical cord blood
title Differentiation potential of human CD133 positive hematopoietic stem cells into motor neuron- like cells, in vitro
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T08%3A35%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differentiation%20potential%20of%20human%20CD133%20positive%20hematopoietic%20stem%20cells%20into%20motor%20neuron-%20like%20cells,%20in%20vitro&rft.jtitle=Journal%20of%20chemical%20neuroanatomy&rft.au=Moghaddam,%20Sepideh%20Alavi&rft.date=2017-12&rft.volume=86&rft.spage=35&rft.epage=40&rft.pages=35-40&rft.issn=0891-0618&rft.eissn=1873-6300&rft_id=info:doi/10.1016/j.jchemneu.2017.07.006&rft_dat=%3Cproquest_cross%3E1924595658%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1924595658&rft_id=info:pmid/28754612&rft_els_id=S0891061817300777&rfr_iscdi=true